Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma - Notification of holding of treasury shares
Company announcement – No. 42 / 2026 Zealand Pharma – Notification of holding of treasury shares Copenhagen, Denmark, August 24, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
Why AI-Driven Drug Discovery Is Becoming Pharma's Next Big Bet
AI is not replacing scientific intuition but rather enhancing early-stage research. My first two years of college were in a special medical school program focused on the courses required to get into a pharmacy program, to become a pharmacist.
Chinese tech, pharma firms eye Hong Kong as springboard for global expansion
Mainland Chinese technology and pharmaceutical companies are using Hong Kong as a launching pad for global expansion, industry leaders have said, as a major state-owned drugmaker weighs whether to invest in the city's Northern Metropolis…
Zealand Pharma - Transactions related to share buy-back program (week 34, 2026)
Company announcement No. 41 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 34, 2026) Copenhagen, Denmark, August 24, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
InnoCare Pharma Limited (INCPF) Q2 2026 Earnings Call Transcript
InnoCare Pharma Limited (INCPF) Q2 2026 Earnings Call August 24, 2026 8:30 AM EDT Jisong Cui - Co-Founder, Chairwoman & CEO Xin Fu - Chief Financial Officer Renbin Zhao - Senior VP of Clinical Development & Medical Research and Executive Director…
LSL PHARMA GROUP REPORTS RECORD REVENUES AND SECOND QUARTER 2026 RESULTS
Record quarterly revenues from both the CMO and Private Label business segments; Results include the commercial launch of the new eye-drops portfolio; Health Canada Remediation plan and production capacity scale-up at Steri-Med progressing as…
Big pharma's next $10 billion gamble: Ozempic for your brain
A new wave of treatments for a rare illness are being touted as the next major breakthrough from the same class of drugs as Ozempic, sparking multibillion-dollar acquisitions from pharmaceutical giants but caution from experts who warn that more…
Natco Pharma invests $14mn in biotech firm eGenesis; total investment at $22mn
Generic drugmaker Natco Pharma is investing an additional $14 million in U.S.-based biotechnology company eGenesis, which is developing genetically engineered, human-compatible organs for transplantation. The latest investment will be made through…
How big pharma targets obesity in China's weight-loss market
SHANGHAI – Weight-loss drugmakers, vying to tighten the belts of Chinese consumers, are promoting obesity awareness in metro stations, exercise studios and soccer stadiums as local restrictions prevent the direct advertising of prescription…
Natco Pharma to invest $14 million in eGenesis Inc
Natco Pharma on Tuesday said it is investing $14 million (over ₹130 crore) in eGenesis Inc, a US-based biotechnology firm, through its two subsidiaries. As part of the transaction, Natco Pharma (Canada) Inc will invest $9.5 million and Natco…
Parkman Healthcare Partners LLC Acquires New Position in Urogen Pharma $URGN
Parkman Healthcare Partners LLC acquired a new position in shares of Urogen Pharma (NASDAQ:URGN - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional…
NervGen Pharma (NASDAQ:NGEN) Given Average Recommendation of 'Moderate Buy' by Analysts
Shares of NervGen Pharma (NASDAQ:NGEN - Get Free Report) have earned a consensus rating of 'Moderate Buy' from the six brokerages that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell…
The Manufacturers Life Insurance Company Purchases New Stake in BridgeBio Pharma, Inc. $BBIO
The Manufacturers Life Insurance Company acquired a new position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission…
Swiss non-profit drugmakers team up as funding shrinks
• Three Geneva-based non-profit drug developers are pooling resources for R&D, advocacy and communications. • Pharma R&D spending on neglected diseases fell from $824 million in 2018 to $623 million in 2024. • Experts are…
CBN, PHARMEXCIL sign MoU to boost pharmaceutical exports
The Central Bureau of Narcotics (CBN) under the finance ministry and the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL), set up by the Ministry of Commerce and Industry, on Monday signed an agreement to boost exports of pharma…
Receive a Daily briefing on Pharma Industry News
Get Started